Histology of good risk non-seminomatous germ cell tumour (NSGCT) patients following retroperitoneal lymph node dissection (PC-RPLND) after four cycles of etoposide and cisplatin (Epx4)

被引：0
|
作者：
Patel, MI [1 ]
Beck, SDW [1 ]
Sheinfeld, J [1 ]
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
来源：
BJU INTERNATIONAL | 2005年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [1] Histology of good risk non-seminomatous germ cell tumor (NSGCT) patients following retroperitoneal lymph node dissection (PC-RPLND) after four cycles of etoposide and cisplatin (EPX4)
    Patel, MI
    Beck, S
    Bosl, GJ
    Motzer, R
    Bajorin, D
    Sheinfeld, J
    JOURNAL OF UROLOGY, 2003, 169 (04): : 176 - 177
  • [2] Comparing the perioperative management of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in patients with pure seminomatous and non seminomatous germ cell tumours, NSGCT
    Pfister, D.
    Albers, P.
    Busch, J.
    Dieckmann, K-P
    Schmelz, H.
    Krege, S.
    Winter, C.
    Schrader, M.
    Honecker, F.
    Heidenreich, A.
    ONKOLOGIE, 2013, 36 : 81 - 81
  • [3] IMPACT OF FERTILITY AFTER PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) FOR PATIENTS WITH NON-SEMINOMATOUS GERM CELLTUMORS (NSGCT)
    Bey, Aaron L.
    Beck, Stephen D. W.
    Bihrle, Richard
    Foster, Richard
    JOURNAL OF UROLOGY, 2009, 181 (04): : 199 - 199
  • [4] Clinical outcome of intermediate-and poor-risk patients with non-seminomatous germ cell testicular cancer (NSGCT) following post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND)
    Shayegan, B
    Carver, BS
    Stephenson, AJ
    Bajorin, DF
    Motzer, RJ
    Bosl, GJ
    Sheinfeld, J
    JOURNAL OF UROLOGY, 2005, 173 (04): : 117 - 117
  • [5] Adjunctive surgeries in postchemotherapy retroperitoneal lymph node dissection in, PC-RPLND, patients with non seminomatous germ cell cancer, NSGCC after cisplatin based chemotherapy
    Pfister, D.
    Albers, P.
    Busch, J.
    Dieckmann, K-P
    Honecker, F.
    Krege, S.
    Winter, C.
    Schmelz, H.
    Schrader, M.
    Heidenreich, A.
    ONKOLOGIE, 2013, 36 : 114 - 114
  • [6] Retrospective Analysis of Postchemotheraphy Retroperitoneal Lymph Node Dissection (PC-RPLND) Results in Patients with Non-Seminomatous Testicular Cancers
    Soydan, Hasan
    Malkoc, Ercan
    Okcelik, Sezgin
    Yilmaz, Omer
    Ates, Ferhat
    Dursun, Furkan
    Karademir, Kenan
    Senkul, Temucin
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (01): : 22 - 27
  • [7] IMPACT OF BLEOMYCIN ON RETROPERITONEAL HISTOLOGY AT POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND) IN GOOD RISK GERM CELL TUMORS
    Cary, K. Clint
    Pedrosa, Jose
    Kaimakliotis, Hristos
    Masterson, TImothy
    Einhorn, Lawrence
    Foster, Richard
    JOURNAL OF UROLOGY, 2014, 191 (04): : E855 - E855
  • [8] Retroperitoneal cancer viability after postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in good risk germ cell tumors (GCTs)
    Taza, Fadi
    Chovanec, Michal
    Snavely, Anna
    Adra, Nabil
    Hanna, Nasser H.
    Cary, Clint
    Masterson, Timothy A.
    Einhorn, Lawrence H.
    Albany, Costantine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] TECHNIQUE AND OUTCOMES FOR ROBOTIC ASSISTED POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN STAGE 2 NON-SEMINOMATOUS GERM CELL TUMOUR (NSGCT)
    Dudderidge, T.
    Pandian, S.
    Nott, D.
    BJU INTERNATIONAL, 2012, 110 : 97 - 97
  • [10] The incidence and implications of disease outside a modified template in men undergoing post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic non-seminomatous germ cell tumors (NSGCT)
    Carver, BS
    Shayegan, B
    Motzer, RJ
    Stasi, J
    Bajorin, DF
    Bosl, GJ
    Sheinfeld, J
    JOURNAL OF UROLOGY, 2006, 175 (04): : 192 - 192
12345